{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:29Z","timestamp":1792785869965,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Stiftung Batzeb\u00e4r"},{"name":"University Children\u2019s Hospital Bern","id":[{"id":"https:\/\/ror.org\/02k9jrs03","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002759","name":"Congenital Adrenal Hyperplasia","doi-asserted-by":"publisher","award":["2019"],"award-info":[{"award-number":["2019"]}],"id":[{"id":"10.13039\/100002759","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Androgen excess in 21-hydroxylase deficiency (21OHD) remains difficult to manage in adolescent females. Combined oral contraceptive(s) (OC) containing ethinylestradiol and progestin modulate ovarian and adrenal steroidogenesis, but their specific impact on 21OHD has not been systematically evaluated. We therefore examined how combined OCs influence the steroid metabolome in young women with classic 21OHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Young women aged 11-24 years with classic 21OHD who planned to initiate combined OC were enrolled. The study comprised 3 visits and included blood sampling and 24-hour urine collection: Visit 1 before OC initiation, Visit 2 during the third OC cycle, and Visit 3 during the sixth OC cycle. Plasma steroids were quantified by liquid chromatography\u2013mass spectrometry and urinary metabolites by gas chromatography\u2013mass spectrometry. Differences in steroid and metabolite levels across visits were assessed using the Friedman test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 20 participants recruited, 17 (median age 16.8 years, range 11-24) completed the study. Compared with baseline, plasma concentrations of 17\u03b1-hydroxyprogesterone, androstenedione, dehydroepiandrosterone, and testosterone decreased significantly (all P &amp;lt; .005), while cortisol increased (P &amp;lt; .001). Urinary 24-hour excretion of androgen metabolites, including 11-oxo-etiocholanolone, declined. Between visits 1 and 3, 8 participants (47%) reduced their hydrocortisone dose in response to biochemical changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combined OCs were observed to modify steroid metabolism and lower androgen levels in women with classic 21OHD. OC therapy may serve as a useful adjunct in the management of androgen excess in this population, particularly when conventional glucocorticoid therapy alone does not achieve satisfactory biochemical control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag160","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:46:59Z","timestamp":1787140019000},"page":"385-395","source":"Crossref","is-referenced-by-count":0,"title":["Biochemical control in young women with congenital adrenal hyperplasia taking oral contraceptives: a prospective observational study"],"prefix":"10.1093","volume":"195","author":[{"given":"Chrysanthi","family":"Kouri","sequence":"first","affiliation":[{"name":"Paediatric Endocrinology, Diabetology and Metabolism, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern , Bern 3010 ,","place":["Switzerland"]},{"name":"Department for BioMedical Research, University of Bern , Bern 3008 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"Sommer","sequence":"additional","affiliation":[{"name":"Institute of Social and Preventive Medicine, University of Bern , Bern 3012 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Cavalieri Costa","sequence":"additional","affiliation":[{"name":"Unidade de Endocrinologia do Desenvolvimento, Laborat\u00f3rio de Horm\u00f4nios e Gen\u00e9tica Molecular LIM42, Hospital Das Clinicas, Faculdade De Medicina, Universidade de Sao Paulo , S\u00e3o Paulo 05403-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela Costa","family":"de Miranda","sequence":"additional","affiliation":[{"name":"Unidade de Endocrinologia do Desenvolvimento, Laborat\u00f3rio de Horm\u00f4nios e Gen\u00e9tica Molecular LIM42, Hospital Das Clinicas, Faculdade De Medicina, Universidade de Sao Paulo , S\u00e3o Paulo 05403-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therina","family":"du Toit","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology and Metabolism, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern , Bern 3010 ,","place":["Switzerland"]},{"name":"Department for BioMedical Research, University of Bern , Bern 3008 ,","place":["Switzerland"]},{"name":"Department of Nephrology and Hypertension, Inselspital, Bern University Hospital , Bern 3010 ,","place":["Switzerland"]},{"name":"University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern , Bern 3010 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Heldt","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Easter Switzerland, Paediatric Endocrinology and Diabetology , St. Gallen 9006 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Hess","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology and Diabetology, Universit\u00e4ts-Kinderklinik Beider Basel (UKBB) , Basel 4031 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Lind\u00e9n Hirschberg","sequence":"additional","affiliation":[{"name":"Women\u2019s and Children\u2019s Health, Karolinska Institutet, and Gynecology and Reproductive Medicine, Karolinska University Hospital , Stockholm 17175 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Markosyan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Yerevan State Medical University Astghik Medical Centre , Yerevan 0025 ,","place":["Armenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3892-0577","authenticated-orcid":false,"given":"Uta","family":"Neumann","sequence":"additional","affiliation":[{"name":"Clinic for Paediatric Endocrinology and Diabetology, Charit\u00e9-Universit\u00e4tsmedizin Berlin , Berlin 13353 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Phan-Hug","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Diabetology, Ensemble Hospitalier de la C\u00f4te , Morges 1110 ,","place":["Switzerland"]},{"name":"H\u00f4pital du Valais , Sion 1951 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Rohayem","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Easter Switzerland, Paediatric Endocrinology and Diabetology , St. Gallen 9006 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Celeste Rotondo","sequence":"additional","affiliation":[{"name":"Department for BioMedical Research, University of Bern , Bern 3008 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4568-5504","authenticated-orcid":false,"given":"Christa E","family":"Fl\u00fcck","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology and Metabolism, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern , Bern 3010 ,","place":["Switzerland"]},{"name":"Department for BioMedical Research, University of Bern , Bern 3008 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5494-2616","authenticated-orcid":false,"given":"Claudia","family":"Boettcher","sequence":"additional","affiliation":[{"name":"Paediatric Endocrinology, Diabetology and Metabolism, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern , Bern 3010 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"11","key":"2026093004234822200_lvag160-B1","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society* clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"2026093004234822200_lvag160-B2","first-page":"425","volume-title":"The adrenal Cortex and its disorders","author":"Miller","year":"2021"},{"issue":"7","key":"2026093004234822200_lvag160-B3","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1210\/jc.2013-1440","article-title":"Approach to the patient: the adult with congenital adrenal hyperplasia","volume":"98","author":"Auchus","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"10108","key":"2026093004234822200_lvag160-B4","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"2026093004234822200_lvag160-B5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/01.OGX.0000062966.93819.5B","article-title":"Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"58","author":"Stikkelbroeck","year":"2003","journal-title":"Obstet Gynecol Surv."},{"issue":"Supplement_1","key":"2026093004234822200_lvag160-B6","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1210\/clinem\/dgae696","article-title":"Clinical manifestations and challenges in adolescent and adult females with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"110","author":"Engberg","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026093004234822200_lvag160-B7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2026093004234822200_lvag160-B8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jsbmb.2017.12.016","article-title":"Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia","volume":"178","author":"Kamrath","year":"2018","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"2","key":"2026093004234822200_lvag160-B9","doi-asserted-by":"publisher","first-page":"bvaa192","DOI":"10.1210\/jendso\/bvaa192","article-title":"11-Oxygenated androgens useful in the setting of discrepant conventional biomarkers in 21-hydroxylase deficiency","volume":"5","author":"Jha","year":"2021","journal-title":"J Endocr Soc."},{"issue":"6","key":"2026093004234822200_lvag160-B10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/09513590902730770","article-title":"Comparison of corticoid substitution versus combined oral contraception administration in the treatment of non-classic adrenal hyperplasia: a prospective study","volume":"25","author":"Fanta","year":"2009","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2026093004234822200_lvag160-B11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2026093004234822200_lvag160-B12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cca.2014.06.018","article-title":"Sex, age, pubertal development and use of oral contraceptives in relation to serum concentrations of DHEA, DHEAS, 17\u03b1-hydroxyprogesterone, \u03944-androstenedione, testosterone and their ratios in children, adolescents and young adults","volume":"437","author":"S\u00f8eborg","year":"2014","journal-title":"Clin Chim Acta"},{"issue":"4","key":"2026093004234822200_lvag160-B13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1172\/JCI104073","article-title":"Studies on the mechanism of the plasma 17-hydroxycorticosteroid elevation induced in man by estrogens","volume":"39","author":"Wallace","year":"1960","journal-title":"J Clin Invest"},{"issue":"4","key":"2026093004234822200_lvag160-B14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1210\/jcem-20-4-495","article-title":"Estrogens and adrenocortical function in man","volume":"20","author":"Peterson","year":"1960","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026093004234822200_lvag160-B15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1471-0528.1975.tb00609.x","article-title":"Cortisol metabolism after oral contraceptives: total plasma cortisol and the free cortisol index","volume":"82","author":"Brien","year":"1975","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"2026093004234822200_lvag160-B16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/00365517309082426","article-title":"Plasma and urinary cortisol in pregnancy and during estrogen-gestagen treatment","volume":"31","author":"Lindholm","year":"1973","journal-title":"Scand J Clin Lab Invest"},{"issue":"2-3","key":"2026093004234822200_lvag160-B17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0009-8981(87)90183-5","article-title":"The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone","volume":"165","author":"Meulenberg","year":"1987","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2026093004234822200_lvag160-B18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1365-2265.2010.03897.x","article-title":"Corticosteroid-binding globulin regulates cortisol pharmacokinetics","volume":"74","author":"Perogamvros","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026093004234822200_lvag160-B19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.contraception.2022.08.009","article-title":"Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: a randomized trial","volume":"116","author":"Kangasniemi","year":"2022","journal-title":"Contraception"},{"issue":"1","key":"2026093004234822200_lvag160-B20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbrc.2017.07.063","article-title":"Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy","volume":"491","author":"Louw-du Toit","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2026093004234822200_lvag160-B21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"issue":"1-2","key":"2026093004234822200_lvag160-B22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mce.2010.05.012","article-title":"Human adrenal LH\/hCG receptors and what they could mean for adrenal physiology and pathology","volume":"329","author":"Rao","year":"2010","journal-title":"Mol Cell Endocrinol."},{"issue":"8990","key":"2026093004234822200_lvag160-B23","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"issue":"aug13 2","key":"2026093004234822200_lvag160-B24","doi-asserted-by":"publisher","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"2026093004234822200_lvag160-B25","doi-asserted-by":"publisher","first-page":"111251","DOI":"10.1016\/j.contraception.2025.111251","article-title":"Risk of venous thromboembolism associated with chlormadinone acetate- and levonorgestrel-containing combined oral contraceptives - insights from the retrospective RIVET-RCS study","volume":"153","author":"De Corte","year":"2026","journal-title":"Contraception"},{"key":"2026093004234822200_lvag160-B26","doi-asserted-by":"publisher","first-page":"769187","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"sup1","key":"2026093004234822200_lvag160-B27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8 Suppl 1","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"issue":"7","key":"2026093004234822200_lvag160-B28","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1210\/clinem\/dgad010","article-title":"Effect of oral contraception on screening tests for primary aldosteronism: a 10-year longitudinal study","volume":"108","author":"Yang","year":"2023","journal-title":"J Clin Endocrinol Metab."},{"issue":"25","key":"2026093004234822200_lvag160-B29","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1007\/s00216-022-03881-3","article-title":"Parallel targeted and non-targeted quantitative analysis of steroids in human serum and peritoneal fluid by liquid chromatography high-resolution mass spectrometry","volume":"414","author":"Andrieu","year":"2022","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"2026093004234822200_lvag160-B30","doi-asserted-by":"publisher","first-page":"e0214549","DOI":"10.1371\/journal.pone.0214549","article-title":"Reference intervals for the urinary steroid metabolome: the impact of sex, age, day and night time on human adult steroidogenesis","volume":"14","author":"Ackermann","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"2026093004234822200_lvag160-B31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ejendo\/lvaf121","article-title":"Predicting treatment outcome in congenital adrenal hyperplasia using urine steroidomics and machine learning","volume":"193","author":"Abawi","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026093004234822200_lvag160-B32","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1210\/jcem.77.2.8345046","article-title":"Pulsatile luteinizing hormone patterns in long term oral contraceptive users","volume":"77","author":"Hemrika","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026093004234822200_lvag160-B33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.fertnstert.2005.12.046","article-title":"Effects of oral contraceptives administered at defined stages of ovarian follicular development","volume":"86","author":"Baerwald","year":"2006","journal-title":"Fertil Steril."},{"issue":"4","key":"2026093004234822200_lvag160-B34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/gye.15.4.259.264","article-title":"Influence of two low-dose oral contraceptives on pulsatile gonadotropin secretion","volume":"15","author":"Schleussner","year":"2001","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"2026093004234822200_lvag160-B35","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1530\/EJE-12-0454","article-title":"Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia","volume":"167","author":"Bachelot","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2026093004234822200_lvag160-B36","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026093004234822200_lvag160-B37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3803\/EnM.2021.1328","article-title":"Epidemiology and long-term adverse outcomes in Korean patients with congenital adrenal hyperplasia: a nationwide study","volume":"37","author":"Kim","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"5","key":"2026093004234822200_lvag160-B38","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1210\/endrev\/bnaf016","article-title":"Contraceptive selection for the endocrine patient: what an endocrinologist should know","volume":"46","author":"Zaman","year":"2025","journal-title":"Endocr Rev."},{"issue":"6","key":"2026093004234822200_lvag160-B39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1056\/NEJMoa2404656","article-title":"Phase 3 trial of crinecerfont in adult congenital adrenal hyperplasia","volume":"391","author":"Auchus","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"2026093004234822200_lvag160-B40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/ejendo\/lvaf130","article-title":"Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules","volume":"193","author":"Arlt","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026093004234822200_lvag160-B41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/17446651.2025.2450423","article-title":"Glucocorticoid therapy in classic congenital adrenal hyperplasia: traditional and new treatment paradigms","volume":"20","author":"Bancos","year":"2025","journal-title":"Expert Rev Endocrinol Metab"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag160\/70733867\/lvag160.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/3\/385\/70733867\/lvag160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/3\/385\/70733867\/lvag160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:24:00Z","timestamp":1790756640000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/195\/3\/385\/8767529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag160","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,21]]}}}